Sequencing of Therapy to Avoid Resistance and the Need for New Antiretroviral Drugs in the Treatment of HIV Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|9|2|172-190

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.9, Iss.2, 2009-04, pp. : 172-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretroviral Therapy: Optimal Sequencing of Therapy to Avoid Resistance

By Martinez-Cajas Jorge L.   Wainberg Mark A.  

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 43-72

Adis International

Access to resources Recommend Favorite

Targeting HIV: antiretroviral therapy and development of drug resistance

By Menendez-Arias L.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 8, 2002-08 ,pp. : 381-388

Elsevier

Access to resources Recommend Favorite

Starting treatment of HIV-1 infection with a simple, but potent, antiretroviral regimen produces comparable virological results as those seen when starting therapy with more drugs

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

The Need for New Antimalarial Drugs Less Prone to Resistance

By  

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 266-269

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: HIV and Antiretroviral Drugs: Current Status and New Challenges

By  

Current Pharmaceutical Design, Vol. 23, Iss. 18, 2017-07 ,pp. : 2551-2551

Bentham Science Publishers

Access to resources Recommend Favorite